Nuclear Medicine: Page 370

MDCT, scintigraphy yield very different reads on wrist fractures

By Tracie L. Thompson

Based on a head-to-head comparison with skeletal scintigraphy, British researchers have reluctantly concluded that MDCT probably shouldn't be the next step after initial x-rays fail to show a suspected wrist fracture.

May 17, 2005

International Isotopes shows Q1 downturn

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes of Idaho Falls, ID, reported sales of $686,000, a 7.7% decrease compared with the $743,000 in revenue posted in the comparable quarter one year ago.

May 16, 2005

Draxis joins Nasdaq biotech index

By AuntMinnie.com staff writers

Canadian pharmaceutical developer Draxis Health said that its stock will be added to the Nasdaq Biotechnology Index.

May 15, 2005

Draxis notches upbeat Q1

By AuntMinnie.com staff writers

Strong growth in contract manufacturing and an uptick in radiopharmaceutical sales fueled a surge in first-quarter revenues for Draxis Health of Mississauga, Ontario.

May 11, 2005

Medx inks Yale distribution deal

By AuntMinnie.com staff writers

Nuclear imaging systems manufacturer Medx has signed a deal with Yale University of New Haven, CT, to be its sole worldwide distributor for a cardiac quantification application, Wackers-Liu CQ.

May 10, 2005

Palatin reports higher sales, lower net loss

By AuntMinnie.com staff writers

Radiopharmaceutical developer Palatin Technologies reported a big gain in revenues and a lower net loss for the company's fiscal third quarter (end-March 31).

May 9, 2005

Cytogen revenues up in Q1, but loss widens

By AuntMinnie.com staff writers

Biopharmaceutical firm Cytogen reported first-quarter total product revenues of $4 million, up 10% compared with the $3.6 million posted last year.

May 4, 2005

BrachySil data to debut at ESTRO

By AuntMinnie.com staff writers

Biomedical nanotechnology firm pSivida of Perth, Australia, said that current data from its BrachySil cancer therapy product investigational trials will be presented at the European Society for Therapeutic and Radiation Oncology (ESTRO) conference in Budapest, Hungary, this week.

May 3, 2005

Digirad revenues rise, but loss widens in Q1

By AuntMinnie.com staff writers

Nuclear medicine vendor Digirad reported first-quarter revenues of $18 million, up 13% compared with the $15.9 million turned in during the first quarter of 2004.

May 2, 2005

Gamma-based imaging proves useful in breast cancer metastases

By Shalmali Pal

Two recent studies have taken a closer look at the role of gamma cameras and gamma probes in tracking the spread of breast cancer. In the first study, Japanese researchers compared SPECT to FDG-PET for detecting bone metastasis to the axial skeleton in breast cancer cases. In the second paper, French authors compared gamma probes for sentinel lymph node detection, which is an important guide for therapeutic choices.

April 28, 2005

Immunomedics to raise $36 million

By AuntMinnie.com staff writers

Radiopharmaceutical firm Immunomedics said it has signed definitive agreements to complete approximately $36 million in financing through the issuance of senior convertible notes and common stock warrants.

April 27, 2005

Draxis names president of radiopharmaceuticals group

Draxis Health of Mississauga, Ontario, has selected Jean-Pierre Robert as the new president of its radiopharmaceuticals division in Montreal.

April 26, 2005

Previous Page

Page 370 of 437

Next Page